Else Nutrition - CEO, Hamutal Yitzhak.
CEO, Hamutal Yitzhak.
Source: Else Nutrition.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Common shares and warrants of Else Nutrition (BABY) will begin trading on the TSX on Tuesday, January 25th under the symbols BABY, BABY.WT and BABY.WT.A.
  • The company’s common shares and warrants will be delisted from the TSXV
  • The uplisting will attract institutional capital and increase overall capital markets exposure
  • Else Nutrition is focused on developing innovative, clean and plant-based food and nutrition products
  • Else Nutrition Holdings (BABY) opened trading at C$1.17 per share

Common shares and warrants of Else Nutrition (BABY) will begin trading on the TSX on Tuesday, January 25, 2022.

The trading symbol for the common shares and warrants on the TSX will remain unchanged as BABY, BABY.WT and BABY.WT.A.

The company’s common shares and warrants will be concurrently delisted from the TSX Venture Exchange.

The TSX is the premier stock exchange for Canadian and international companies, offering enhanced visibility, liquidity, and access to capital. ELSE believes that a TSX listing will facilitate access to a broader range of investors.

“Listing on the TSX is a confirmation of our progress and marks another milestone on our journey, as we take significant strides in preparing ELSE for global growth,” said Hamutal Yitzhak, ELSE co-founder & CEO.

“This up-listing will serve to increase the exposure of our story and business potential to additional investors in the capital markets community and will further support the growth of our investor base.”

Else Nutrition is focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula.

Else Nutrition Holdings (BABY) opened trading at C$1.17 per share.

More From The Market Herald

" Komo Plant-Based Foods (CSE:YUM) is building out its U.S. expansion

Komo Plant-Based Foods (YUM) has appointed Caboodle Consulting LLC to support the company’s retail expansion in the United States.

" Your Answer to the Formula Shortage Crisis (TSX: BABY)

 (Image via Else Nutrition Holdings Inc.)
Perk Labs - CEO, Jonathan Hoyles.

" Perk Labs (CSE:PERK) enters Toronto market

Perk Labs (PERK) has signed a franchise agreement in downtown Toronto.

" Optimi (CSE:OPTI) cultivates first batch of mushrooms

Optimi Health (OPTI) successfully completed its first batch of psilocybin cubensis and functional mushrooms.